Pyxis Oncology (NASDAQ:PYXS – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report issued on Saturday. Several other research firms have also issued reports on PYXS. Guggenheim boosted their price target on Pyxis Oncology from $5.00 to $7.00 and gave the [...]
Wall Street Zen Upgrades Pyxis Oncology (NASDAQ:PYXS) to Hold
